Bristol Myers Squibb (BMY) Net Cash Flow (2009 - 2026)
Bristol Myers Squibb (BMY) reported Net Cash Flow of -$587.0 million for Q1 2026, down 227.06% year-over-year from $462.0 million in Q1 2025, and up 89.35% on a QoQ basis from -$5.5 billion in Q4 2025.
Bristol Myers Squibb (BMY) has 18 years of Net Cash Flow data on file, last reported at -$587.0 million in Q1 2026.
- Quarterly Net Cash Flow fell 227.06% year-over-year to -$587.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.4 billion (down 187.62% YoY) and the FY2025 annual result came in at -$324.0 million, up 68.7% from the prior year.
- Net Cash Flow grew to -$587.0 million in Q1 2026 per BMY's latest filing, from -$5.5 billion in the prior quarter.
- Across five years, Net Cash Flow topped out at $3.9 billion in Q4 2023 and bottomed at -$5.5 billion in Q4 2025.
- The 5-year median for Net Cash Flow is -$587.0 million (2026), against an average of -$279.7 million.
- The widest annual swing landed in 2022, when Net Cash Flow tumbled 2768.97%; it then soared 285.59% in 2024.
- Tracing BMY's Net Cash Flow over 5 years: stood at $1.3 billion in 2022, then soared by 204.24% to $3.9 billion in 2023, then slumped by 32.84% to $2.6 billion in 2024, then tumbled by 311.96% to -$5.5 billion in 2025, then jumped by 89.35% to -$587.0 million in 2026.
- Per Business Quant, the three latest BMY Net Cash Flow figures stand at -$587.0 million (Q1 2026), -$5.5 billion (Q4 2025), and $3.1 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | -2.05 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 2.00 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 4.17 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -9.27 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 2.91 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 75.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 544.00 Mn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -587.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -587.00 Mn |
| Mar 31, 2026 | -587.00 Mn |
| Dec 31, 2025 | -5.51 Bn |
| Dec 31, 2025 | -5.51 Bn |
| Sep 30, 2025 | 3.12 Bn |
| Sep 30, 2025 | 3.12 Bn |
| Jun 30, 2025 | 1.61 Bn |
| Jun 30, 2025 | 1.61 Bn |
| Mar 31, 2025 | 462.00 Mn |
| Mar 31, 2025 | 462.00 Mn |
| Dec 31, 2024 | 2.60 Bn |
| Dec 31, 2024 | 2.60 Bn |
| Sep 30, 2024 | 1.52 Bn |
| Sep 30, 2024 | 1.52 Bn |
| Jun 30, 2024 | -3.02 Bn |
| Jun 30, 2024 | -3.02 Bn |
| Mar 31, 2024 | -2.14 Bn |
| Mar 31, 2024 | -2.14 Bn |
| Dec 31, 2023 | 3.87 Bn |
| Dec 31, 2023 | 3.87 Bn |
| Sep 30, 2023 | -819.00 Mn |
| Sep 30, 2023 | -819.00 Mn |
| Jun 30, 2023 | -615.00 Mn |
| Jun 30, 2023 | -615.00 Mn |
| Mar 31, 2023 | -290.00 Mn |
| Mar 31, 2023 | -290.00 Mn |
| Dec 31, 2022 | 1.27 Bn |
| Dec 31, 2022 | 1.27 Bn |
| Sep 30, 2022 | -2.94 Bn |
| Sep 30, 2022 | -2.94 Bn |
| Jun 30, 2022 | -1.55 Bn |
| Jun 30, 2022 | -1.55 Bn |
| Mar 31, 2022 | -1.75 Bn |
| Mar 31, 2022 | -1.75 Bn |
| Dec 31, 2021 | 491.00 Mn |
| Dec 31, 2021 | 491.00 Mn |
| Sep 30, 2021 | 2.51 Bn |
| Sep 30, 2021 | 2.51 Bn |
| Jun 30, 2021 | 58.00 Mn |
| Jun 30, 2021 | 58.00 Mn |
| Mar 31, 2021 | -3.61 Bn |
| Mar 31, 2021 | -3.61 Bn |
| Dec 31, 2020 | -4.97 Bn |
| Dec 31, 2020 | -4.97 Bn |
| Sep 30, 2020 | -533.00 Mn |
| Sep 30, 2020 | -533.00 Mn |
| Jun 30, 2020 | 4.06 Bn |
| Jun 30, 2020 | 4.06 Bn |
| Mar 31, 2020 | 3.49 Bn |
| Mar 31, 2020 | 3.49 Bn |
| Dec 31, 2019 | -17.68 Bn |
| Dec 31, 2019 | -17.68 Bn |
| Sep 30, 2019 | 2.11 Bn |
| Sep 30, 2019 | 2.11 Bn |
| Jun 30, 2019 | 21.07 Bn |
| Jun 30, 2019 | 21.07 Bn |
| Mar 31, 2019 | 421.00 Mn |
| Mar 31, 2019 | 421.00 Mn |
| Dec 31, 2018 | 1.52 Bn |
| Dec 31, 2018 | 1.52 Bn |
| Sep 30, 2018 | 412.00 Mn |
| Sep 30, 2018 | 412.00 Mn |
| Jun 30, 2018 | -306.00 Mn |
| Jun 30, 2018 | -306.00 Mn |
| Mar 31, 2018 | -90.00 Mn |
| Mar 31, 2018 | -90.00 Mn |
| Dec 31, 2017 | 784.00 Mn |
| Dec 31, 2017 | 784.00 Mn |
| Sep 30, 2017 | 1.15 Bn |
| Sep 30, 2017 | 1.15 Bn |
| Jun 30, 2017 | -446.00 Mn |
| Jun 30, 2017 | -446.00 Mn |
| Mar 31, 2017 | -355.00 Mn |
| Mar 31, 2017 | -355.00 Mn |
| Dec 31, 2016 | 854.00 Mn |
| Dec 31, 2016 | 854.00 Mn |
| Sep 30, 2016 | 490.00 Mn |
| Sep 30, 2016 | 490.00 Mn |
| Jun 30, 2016 | 293.00 Mn |
| Jun 30, 2016 | 293.00 Mn |
| Mar 31, 2016 | 248.00 Mn |
| Mar 31, 2016 | 248.00 Mn |
| Dec 31, 2015 | -1.46 Bn |
| Dec 31, 2015 | -1.46 Bn |
| Sep 30, 2015 | -238.00 Mn |
| Sep 30, 2015 | -238.00 Mn |
| Jun 30, 2015 | -2.09 Bn |
| Jun 30, 2015 | -2.09 Bn |
| Mar 31, 2015 | 698.00 Mn |
| Mar 31, 2015 | 698.00 Mn |
| Dec 31, 2014 | 692.00 Mn |
| Dec 31, 2014 | 692.00 Mn |
| Sep 30, 2014 | 539.00 Mn |
| Sep 30, 2014 | 539.00 Mn |
| Jun 30, 2014 | -941.00 Mn |
| Jun 30, 2014 | -941.00 Mn |
| Mar 31, 2014 | 1.64 Bn |
| Mar 31, 2014 | 1.64 Bn |
| Dec 31, 2013 | 1.81 Bn |
| Dec 31, 2013 | 1.81 Bn |
| Sep 30, 2013 | -42.00 Mn |
| Sep 30, 2013 | -42.00 Mn |
| Jun 30, 2013 | 452.00 Mn |
| Jun 30, 2013 | 452.00 Mn |
| Mar 31, 2013 | -311.00 Mn |
| Mar 31, 2013 | -311.00 Mn |
| Dec 31, 2012 | 155.00 Mn |
| Dec 31, 2012 | 155.00 Mn |
| Sep 30, 2012 | -1.31 Bn |
| Sep 30, 2012 | -1.31 Bn |
| Jun 30, 2012 | 510.00 Mn |
| Jun 30, 2012 | 510.00 Mn |
| Mar 31, 2012 | -3.48 Bn |
| Mar 31, 2012 | -3.48 Bn |
| Dec 31, 2011 | 1.31 Bn |
| Dec 31, 2011 | 1.31 Bn |
| Sep 30, 2011 | 831.00 Mn |
| Sep 30, 2011 | 831.00 Mn |
| Jun 30, 2011 | 254.00 Mn |
| Jun 30, 2011 | 254.00 Mn |
| Mar 31, 2011 | -1.65 Bn |
| Mar 31, 2011 | -1.65 Bn |
| Dec 31, 2010 | -2.55 Bn |
| Dec 31, 2010 | -2.55 Bn |
| Sep 30, 2010 | 1.63 Bn |
| Sep 30, 2010 | 1.63 Bn |
| Jun 30, 2010 | 792.00 Mn |
| Jun 30, 2010 | 792.00 Mn |
| Mar 31, 2010 | -2.54 Bn |
| Mar 31, 2010 | -2.54 Bn |
| Dec 31, 2009 | 1.31 Bn |
| Dec 31, 2009 | 1.31 Bn |
| Sep 30, 2009 | -1.17 Bn |
| Sep 30, 2009 | -1.17 Bn |